Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolLON:CSRT
CUSIPN/A
Phone+44-1442-867920
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.55%
Return on Equity6.29%
Return on Assets2.99%
Miscellaneous
EmployeesN/A
Outstanding Shares49,280,000
Market Cap£567.74 million
Consort Medical (LON:CSRT) Frequently Asked Questions
What is Consort Medical's stock symbol?
Consort Medical trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."
How often does Consort Medical pay dividends? What is the dividend yield for Consort Medical?
Consort Medical announced a dividend on Thursday, June 14th. Stockholders of record on Thursday, September 27th will be paid a dividend of GBX 13.56 per share on Friday, October 26th. This represents a dividend yield of 1.1%. The ex-dividend date of this dividend is Thursday, September 27th. This is a boost from Consort Medical's previous dividend of $7.44. The official announcement can be seen at this link. View Consort Medical's Dividend History.
What price target have analysts set for CSRT?
4 analysts have issued 1-year price targets for Consort Medical's shares. Their forecasts range from GBX 1,250 to GBX 1,333. On average, they expect Consort Medical's share price to reach GBX 1,291.50 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price. View Analyst Price Targets for Consort Medical.
What is the consensus analysts' recommendation for Consort Medical?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Consort Medical in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Consort Medical.
Who are some of Consort Medical's key competitors?
Some companies that are related to Consort Medical include Corindus Vascular Robotics (CVRS), Ekf Diagnostics (EKF), Bioquell (BQE), Immunodiagnostic Systems (IDH), Zecotek Photonics (ZMS), Theralase Technologies (TLT), LiDCO Group (LID), Medaphor Group (MED), InspireMD (NSPR), Lucid (LCDX), Verisante Technology (VRS) and Deltex Medical Group (DEMG).
Who are Consort Medical's key executives?
Consort Medical's management team includes the folowing people:
- Mr. Jonathan M. Glenn, CEO & Exec. Director (Age 49)
- Mr. Paul Hayes, CFO, Company Sec. & Exec. Director (Age 51)
- Mr. Iain Lindsay, Interim Group Gen. Counsel
- Ms. Lisa King, Director of HR
- Dr. Keyvan Djamarani, Managing Director of Bespak
Has Consort Medical been receiving favorable news coverage?
Media stories about CSRT stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Consort Medical earned a media and rumor sentiment score of 0.11 on Accern's scale. They also assigned news stories about the company an impact score of 47.34 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for Consort Medical.
How do I buy shares of Consort Medical?
Shares of CSRT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Consort Medical's stock price today?
One share of CSRT stock can currently be purchased for approximately GBX 1,164.
How big of a company is Consort Medical?
Consort Medical has a market capitalization of £567.74 million.
How can I contact Consort Medical?
Consort Medical's mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The company can be reached via phone at +44-1442-867920.
MarketBeat Community Rating for Consort Medical (LON CSRT)
MarketBeat's community ratings are surveys of what our community members think about Consort Medical and other stocks. Vote "Outperform" if you believe CSRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CSRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
